References
- Sinha VR, Kumria R. (2001). Polysaccharides in colon-specific drug delivery. Int J Pharm, 224:19–38.
- Sinha VR, Kumria R. (2003). Microbially triggered drug delivery to the colon. Eur J Pharm Sci, 18:3–18.
- Ashford M, Fell JT. (1994). Targeting drugs to the colon: delivery systems for oral administration. J Drug Target, 2:241–257.
- Akhgari A, Sadeghi F, Garekani HA. (2006). Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets. Int J Pharm, 320:137–142.
- Bauer KH, Wohlschlegel CH. (1992). Review about novel pharmaceutical excipients for colon-targeting. Drugs Germany, 35:85–89.
- Sawada T, Sako K, Fukui M, Yokohama S, Hayashi M. (2003). A new index, the core erosion ratio, of compression-coated timed-release tablets predicts the bioavailability of acetaminophen. Int J Pharm, 265:55–63.
- Leopold CS. (1999). Coated dosage forms for colon-specific drug delivery. Pharm Sci Technol Today, 2:197–204.
- Lai H, Lin K, Zhang W, Zhang Z, Jie L, Wu Y et al. (2010). Development of pH- and enzyme-controlled, colon-targeted, pulsed delivery system of a poorly water-soluble drug: preparation and in vitro evaluation. Drug Dev Ind Pharm, 36:81–92.
- Zhao W, Song L, Deng H, Yao H. (2009). Hydration, erosion, and release behavior of guar-based hydrophilic matrix tablets containing total alkaloids of Sophora alopecuroides. Drug Dev Ind Pharm, 35:594–602.
- Zou M, Wang Y, Xu C, Cheng G, Ren J, Wu G. (2009). Wax-matrix tablet for time-dependent colon-specific delivery system of sophora flavescens Aiton: preparation and in vivo evaluation. Drug Dev Ind Pharm, 35:224–233.
- Pickart L, Thaler MM. (1973). Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nature New Biol, 243:85–87.
- Pickart L, Freedman JH, Loker WJ, Peisach J, Perkins CM, Stenkamp RE et al. (1980). Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells. Nature, 288:715–717.
- Conato C, Gavioli R, Guerrini R, Kozlowski H, Mlynarz P, Pasti C et al. (2001). Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity. Biochim Biophys Acta, 1526:199–210.
- Maquart FX, Bellon G, Pasco S, Monboisse JC. (2005). Matrikines in the regulation of extracellular matrix degradation. Biochimie, 87:353–360.
- Arul V, Gopinath D, Gomathi K, Jayakumar R. (2005). Biotinylated GHK peptide incorporated collagenous matrix: a novel biomaterial for dermal wound healing in rats. J Biomed Mater Res Part B Appl Biomater, 73:383–391.
- Massey P, Patt L, D’Aoust JC. (1992). The effect of glycyl-histidyl-lysine copper. Chelate on the healing of diabetic ulcers: a pilot study. Wounds, 4:8–21.
- Naito Y, Yoshikawa T. (2005). Role of matrix metalloproteinases in inflammatory bowel disease. Mol Aspects Med, 26:379–390.
- Siméon A, Monier F, Emonard H, Gillery P, Birembaut P, Hornebeck W et al. (1999). Expression and activation of matrix metalloproteinases in wounds: modulation by the tripeptide–copper complex glycyl-l-histidyl-l-lysine–Cu2+. J Invest Dermatol, 112:957–964.
- Siméon A, Emonard H, Hornebeck W, Maquart FX. (2000). The tripeptide–copper complex glycyl-l-histidyl-l-lysine–Cu2+ stimulates matrix metalloproteinase-2 expression by fibroblast cultures. Life Sci, 67:2257–2265.
- Turkoglu M, Ugurlu T. (2002). In vitro evaluation of pectin–HPMC compression coated 5-aminosalicylic acid tablets for colonic delivery. Eur J Pharm Biopharm, 53:65–73.
- Ugurlu T, Turkoglu M, Gurer US, Akarsu BG. (2007). Colonic delivery of compression coated nisin tablets using pectin/HPMC polymer mixture. Eur J Pharm Biopharm, 67:202–210.
- Mazurowska L, Mojski M. (2007). ESI-MS study of the mechanism of glycyl-l-histidyl-l-lysine–Cu(II) complex transport through model membrane of stratum corneum. Talanta, 72:650–654.
- Chang WH, Cheng YK, Choi MMF, Lee AWM, Wong MS, Wong WY. (2004). Application of a Low-Cost Four-LED based photometer for environmental analysis. Chem Educ J, 7:13:162–170.
- Esposito E, Cortesi R, Luca G, Nastruzzi C. (2001). Pectin-based microspheres: a preformulatory study. Ann N Y Acad Sci, 944:160–179.
- Dashora A, Jain CP. (2009). Development and characterization of pectin–prednisolone microspheres for colon targeted delivery. Int J Chem Tech Res, 1:751–757.
- Paharia A, Yadav AK, Rai G, Jain SK, Pancholi SS, Agrawal GP. (2007). Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting. AAPS Pharmscitech, 8:12.
- Yamamoto N, Kuwata K. (2009). DFT studies on redox properties of copper-chelating cuprizone: usually high valent copper (II) state. J Mol Struct, 895:52–56.
- Rumori P, Cerda V. (2003). Reversed flow injection and sandwich sequential injection methods for the spectrophotometric determination of copper (II) with cuprizone. Anal Chim Acta, 486:227–235.
- Sriamornsak P, Nunthanid J. (1998). Calcium pectinate gel beads for controlled release drug delivery: I. preparation and in vitro release studies. Int J Pharm, 160:207–212.
- Esposito E, Cortesi R, Nastruzzi C. (1996). Gelatin microspheres: influence of preparation parameters and thermal treatment on chemico-physical and biopharmaceutical properties. Biomaterials, 17:2009–2020.
- El-Gibaly L. (2002). Oral delayed-release system based on Zn-pectinate gel (ZPG) microparticles as an alternative carrier to calcium pectinate beads for colonic drug delivery. Int J Pharm, 232:199–211.
- Sriamornsak P. (1998). Investigation of pectin as a carrier for oral delivery of proteins using calcium pectinate gel beads. Int J Pharm, 169:213–230.
- Sriamornsak P. (1999). Effect of calcium concentration, hardening agent and drying condition on release characteristics of oral proteins from calcium pectinate gel beads. Eur J Pharm Sci, 8:221–227.